Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...

Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.

Two Seas Capital has come out against Core Scientific's proposed all-stock acquisition by AI cloud provider CoreWeave.

Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of ...

CoreWeave reported strong Q2 revenue, but profitability lagged and shares fell in after hours trading amid rising costs and ...

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.

Two Seas Capital is challenging Core Scientific’s $9 billion sale to CoreWeave, arguing the terms significantly undervalue ...

Two Seas Capital opposes CoreWeave’s acquisition of Core Scientific, citing shareholder risk and sparking debate on AI ...

CoreWeave’s acquisition of Core Scientific is facing shareholder pushback, sparking a rally in AI tokens and centralization questions.

Core Scientific's biggest active shareholder penned a letter indicating that they intend to vote against the proposed buyout ...